Platelet-Rich Plasma for Bone Fracture Treatment: A Systematic Review of Current Evidence in Preclinical and Clinical Studies

被引:25
|
作者
Zhang, Yangming [1 ]
Xing, Fei [1 ]
Luo, Rong [1 ]
Duan, Xin [1 ]
机构
[1] Sichuan Univ, West China Hosp, Dept Orthopaed, Chengdu, Peoples R China
基金
中国国家自然科学基金;
关键词
platelet-rich plasma; platelet; fracture; osteoblasts; growth factors; systematic review; GROWTH-FACTOR; HUMAN OSTEOBLASTS; FUNCTION IMPROVEMENT; IN-VITRO; PROLIFERATION; PRP; CELLS; FIBRIN; DIFFERENTIATION; REGENERATION;
D O I
10.3389/fmed.2021.676033
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Recently, there is an increasing interest in the therapeutic potential of platelet-rich plasma (PRP) for bone fracture treatment. Nevertheless, the effect of PRP for bone fracture treatment remains controversial and is still a matter of discussion. Therefore, we performed a systematic review to evaluate the efficacy and safety of PRP injection for treatment of bone fracture. Methods: The main bibliographic databases, including Medline, PubMed, Embase, Web of Science, and the Cochrane library, were comprehensively searched for studies focusing on the application of platelet-rich plasma (PRP) on bone fracture treatment. All relevant articles were screened for eligibility and subdivided into the preclinical and clinical studies. Data were extracted and presented systematically. Results: Finally, twenty-six in vitro preclinical studies (basic studies), nine in vivo preclinical studies (animal studies), and nine clinical studies, met the selection criteria, and were included in the present systematic review. Preclinical studies showed an overall positive effect of PRP on osteoblast-like cells in vitro and bone healing in animal models. The most used treatment for bone fracture in animal and clinical studies is fixation surgery combined with PRP injection. The clinical studies reported PRP shortened bony healing duration, and had no positive effect on improving the healing rate of closed fractures. However, the results of functional outcomes are controversial. Additionally, compared with control group, PRP would not increase the rate of postoperative wound infection. Conclusion: The present systematic review confirmed the continuing interests of PRP as an additional treatment for bone fracture. Preclinical studies highlighted the potential value of PRP as promising therapy for bone fracture. However, the preclinical evidence did not translate into a similar result in the clinical studies. In addition, types of fractures and procedures of PRP preparation are heterogeneous in enrolled studies, which might result in controversial results. Meanwhile, characteristics of PRP, such as platelet concentration, the numbers of leukocytes, still need to be determined and further research is required.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Platelet-rich plasma for the treatment of erectile dysfunction: a systematic review of preclinical and clinical studies
    Poulios, Evangelos
    Mykoniatis, Ioannis
    Pyrgidis, Nikolaos
    Kalyvianakis, Dimitrios
    Hatzichristou, Dimitrios
    SEXUAL MEDICINE REVIEWS, 2023, 11 (04) : 359 - 368
  • [2] Platelet-rich plasma in osteoarthritis treatment: review of current evidence
    Gato-Calvo, Lucia
    Magalhaes, Joana
    Ruiz-Romero, Cristina
    Blanco, Francisco J.
    Burguera, Elena F.
    THERAPEUTIC ADVANCES IN CHRONIC DISEASE, 2019, 10 : 1 - 18
  • [3] Treatment of knee osteoarthritic pain with platelet-rich plasma: a systematic review of clinical studies
    Aiyer, Rohit
    Noori, Selaiman
    Schirripa, Frank
    Schirripa, Michael
    Aboud, Talal
    Jain, Sameer
    Gulati, Amitabh
    Puttanniah, Vinay
    Gungor, Semih
    Hunter, Corey
    PAIN MANAGEMENT, 2021, 11 (04) : 419 - 431
  • [4] Platelet-rich plasma for skin rejuvenation: A systematic review of the clinical evidence
    Ismail, Aliaa
    Maisel, Amanda
    Poon, Emily
    Serrano, Linda
    Grushchak, Solomiya
    West, Dennis P.
    Alam, Murad
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB223 - AB223
  • [5] Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration
    G. Filardo
    E. Kon
    A. Roffi
    B. Di Matteo
    M. L. Merli
    M. Marcacci
    Knee Surgery, Sports Traumatology, Arthroscopy, 2015, 23 : 2459 - 2474
  • [6] Platelet-rich plasma: why intra-articular? A systematic review of preclinical studies and clinical evidence on PRP for joint degeneration
    Filardo, G.
    Kon, E.
    Roffi, A.
    Di Matteo, B.
    Merli, M. L.
    Marcacci, M.
    KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY, 2015, 23 (09) : 2459 - 2474
  • [7] The clinical use of platelet-rich plasma in the promotion of bone healing: A systematic review
    Griffin, X. L.
    Smith, C. M.
    Costa, M. L.
    INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED, 2009, 40 (02): : 158 - 162
  • [8] Platelet-Rich Plasma Therapy: A Systematic Literature Review and Evidence For Clinical Use
    Redler, Lauren H.
    Thompson, Scott A.
    Hsu, Stephanie H.
    Ahmad, Christopher S.
    Levine, William N.
    PHYSICIAN AND SPORTSMEDICINE, 2011, 39 (01): : 42 - 51
  • [9] Platelet-rich plasma: evidence for the treatment of patellar and Achilles tendinopathy—a systematic review
    Di Matteo B.
    Filardo G.
    Kon E.
    Marcacci M.
    MUSCULOSKELETAL SURGERY, 2015, 99 (1) : 1 - 9
  • [10] Platelet-rich plasma for the treatment of bone defects: from pre-clinical rational to evidence in the clinical practice. A systematic review
    Roffi, Alice
    Di Matteo, Berardo
    Krishnakumar, Gopal Shankar
    Kon, Elizaveta
    Filardo, Giuseppe
    INTERNATIONAL ORTHOPAEDICS, 2017, 41 (02) : 221 - 237